Polysaccharide-decorated nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 58, Issue 2, 2004, Pages 327-341

  Lemarchand, Caroline ^a,b   Gref, Ruxandra ^a   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b BioAlliance Pharma   (France)

Author keywords

Cancer therapy; Mucoadhesion; Nanoparticles; Polysaccharide; Surface characterization; Surface modification; Targeting; Tumour imaging

Indexed keywords

2 DIETHYLAMINOETHANOL; CARBOXYMETHYLDEXTRAN; CHITOSAN; COPOLYMER; CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; DEXTRAN; DEXTRAN SULFATE; DIETHYLAMINOETHYLDEXTRAN; DNA; HEPARIN; HYALURONIC ACID; IRON OXIDE; MACROGOL; NANOPARTICLE; OLIGONUCLEOTIDE; OROSOMUCOID; PECTIN; POLY(METHYL METHACRYLATE); POLYALKYLCYANOACRYLATE; POLYCAPROLACTONE; POLYGLACTIN; POLYISOBUTYLCYANOACRYLATE; POLYLACTIC ACID; POLYLYSINE; POLYMER; POLYSACCHARIDE; POLYVINYL ALCOHOL; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CHEMICAL STRUCTURE; CIRCULATION TIME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; EMULSION; GENE DELIVERY SYSTEM; HUMAN; HYDROPHOBICITY; HYPERTHERMIC THERAPY; NEUTRON CAPTURE THERAPY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; REVIEW; ZETA POTENTIAL;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CONTRAST MEDIA; DNA; DRUG CARRIERS; GENE THERAPY; HUMANS; NANOSTRUCTURES; NEOPLASMS; OLIGONUCLEOTIDES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POLYSACCHARIDES;

EID: 3843123185     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.02.016     Document Type: Review

References (105)

1. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603
2. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M. Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84:1995;493-498
3. Peracchia M.T., Vauthier C., Desmaele D., Gulik A., Dedieu J.C., Demoy M., d'Angelo J., Couvreur P. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm. Res. 15:1998;550-556
4. Gref R. Surface-engineered nanoparticles as drug carriers. Baraton M.I. Synthesis, functionalization and surface treatment of nanoparticles. 2002;233-256 American Scientific Publishers
5. Barratt G. Colloidal drug carriers: achievements and perspectives. Cell. Mol. Life Sci. 60:2003;21-37
6. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebeke J., Renoir M., d'Angelo J., Cattel L., Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89:2000;1452-1464
7. Listinsky J.J., Siegal G.P., Listinsky C.M. alpha-L-Fucose, a potentially critical molecule in pathologic processes including neoplasia. Am. J. Clin. Pathol. 110:1998;425-440
8. Stahn R., Zeisig R. Cell adhesion inhibition by glycoliposomes: effects of vesicle diameter and ligand density. Tumor Biol. 21:2000;176-186
9. Dumitriu S. Polysaccharides as biomaterials. Dumitriu S. Polymeric Biomaterials. 2001;1-61 Marcel Dekker, New York
10. Na K., Park K.-H., Kim S.W., Bae Y.H. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with hepatoma cell line (HepG2). J. Control. Release. 69:2000;225-236
11. Schauer R. Sialic acids and their role as biological masks. Trends Biochem. Sci. 10:1985;357-360
12. Jancik J.M., Schauer R., Andres K.H., Von Dürinng M. Sequestration of neuraminidase-treated erythrocytes. Cell Tissue Res. 186:1978;209-226
13. Fernandez-Urrusumo R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16:1999;1576-1581
14. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189
15. Gurny R., Ibrahim H., Aebi A., Buri P., Wilson C.G., Washington N., Edman P., Camber O. Design and evaluation of controlled release systems for the eye. J. Control. Release. 6:1987;367-373
16. Saettone M.F., Chetoni P., Torracca M.T., Burgalassi S., Giannaccini B. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int. J. Pharm. 51:1989;203-212
17. Lehr C.-M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48
18. Durrani A.M., Farr S.J., Kellaway I.W. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye. Int. J. Pharm. 118:1995;243-250
19. Zimmer A., Chetoni P., Saettone M.F., Zerbe H., Kreuter J. Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers. J. Control. Release. 33:1995;31-46
20. Langer K., Mutschler E., Lambrecht G., Mayer D., Troschau G., Stieneker F., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. Part III. Evaluation as drug delivery system for ophthalmic applications. Int. J. Pharm. 158:1997;219-231
21. Woddle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171-199
22. Allen T.M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Del. Rev. 13:1994;285-309
23. Yerushalmi N., Margalit R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch. Biochem. Biophys. 349:1998;21-26
24. Cansell M., Parisel C., Jozefonvicz J., Letouneur D. Liposomes coated with chemically modified dextrans interact with human endothelial cells. J. Biomed. Mater. Res. 44:1999;140-148
25. Letourneur D., Parisel C., Prigent-Richard S., Cansell M. Interactions of functionalized dextran-coated liposomes with vascular smooth muscle cells. J. Control. Release. 65:2000;83-91
26. Venkatesan N., Vyas S.P. Polysaccharide coated liposomes for oral immunization - development and characterization. Int. J. Pharm. 203:2000;169-177
27. Cho C.S., Jeong Y.I., Ishihara T., Takei R., Park J.U., Park K.H. Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. Biomaterials. 18:1996;323-326
28. Maruyama A., Ishihara T., Adachi N., Akaike T. Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier. Biomaterials. 15:1994;1035-1042
29. Deguchi S., Akiyoshi K., Sunamoto J. Solution property of hydrophobized pullulan conjugated with poly(ethylene pxide)-poly(propylene oxide) block copolymer. Formation of nanoparticles and their thermosensitivity. Macromol. Rapid Commun. 15:1994;705-711
30. Akiyoshi K., Sunamoto J. Supramolecular assembly of hydrophobized polysaccharides. Supramol. Sci. 3:1996;157-163
31. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release. 54:1998;313-320
32. Normura Y., Ikeda M., Yamaguchi N., Aoyama Y., Akiyoshi K. Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. Fed. Eur. Biochem. Soc. Lett. 553:2003;271-276
33. Na K., Lee T.B., Park K.-H., Shin E.-K., Lee Y.-B., Choi H.-K. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18:2003;165-173
34. Francis M., Lavoie L., Winnik F., Leroux J.C. Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkylether polymeric micelles. Eur. J. Pharm. Sci. 56:2003;337-346
35. Soma C.E., Dubernet C., Barratt G., Nemati F., Appel M., Benita S., Couvreur P. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumour cells after their capture by macrophages. Pharm. Res. 16:1999;1710-1716
36. Goto M., Arakawa M., Sato T., Kondo H., Sunamoto J. Specific rejection of glycophorin-reconstituted liposomes by human phagocytes. Chem. Lett. 1987;1935-1938
37. Sunamoto J., Sakai K., Sato T., Kondo H. Molecular recognition of polysaccharide-coated liposomes. Importance of sialic acid moiety on liposomal surface. Chem. Lett. 1988;1781-1784
38. Jones M.N. Carbohydrate-mediated liposomal targeting and drug delivery. Adv. Drug Del. Rev. 13:1994;215-250
39. Olivier J.-C., Vauthier C., Taverna M., Ferrier D., Couvreur P. Preparation and characterization of biodegradable poly(isobutylcyano acrylate) nanoparticles with the surface modified by the adsorption of proteins. Colloids Surfaces B: Biointerfaces. 4:1995;349-356
40. Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P.J. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31:1979;331-332
41. Rouzes C., Gref R., Leonard M., De Sousa Delgado A., Dellacherie E. Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique. J. Biomed. Mater. Res. 50:2000;557-565
42. Barbault-Foucher S., Gref R., Russo P., Guechot J., Bochot A. Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J. Control. Release. 83:2002;365-375
43. Janes K.A., Calvo P., Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Del. Rev. 47:2001;83-97
44. Vila A., Sanchez A., Tobio M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Release. 78:2002;15-24
45. Coombes A.G.A., Tasker S., Lindblad M., Holmgren J., Hoste K., Toncheva V., Schacht E., Davis M.C., Ilum L., Davis S.S. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Biomaterials. 18:1997;1153-1161
46. Rouzes C., Durand A., Leonard M., Dellacherie E. Surface activity and emulsification properties of hydrophobically modified dextrans. J. Colloid Interface Sci. 253:2002;217-223
47. Rouzes C., Leonard M., Durand A., Dellacherie E. Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres. Colloids Surfaces B: Biointerfaces. 32:2003;125-135
48. Maruyama A., Ishihara T., Kim J.-S., Kim S.W., Akaike T. Design of multi-layered nanoparticles as a DNA carrier. Colloids Surfaces A: Physicochem. Eng. Aspects. 153:1999;439-443
49. Goetze T., Gansau C., Buske N., Roeder M., Görnert M., Bahr M. Biocompatible magnetic core/shell nanoparticles. J. Magn. Magn. Mater. 252:2002;399-402
50. Pouliquen D., Le Jeune J.J., Perdrisot R., Ermias A., Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn. Reson. Imaging. 9:1991;275-283
51. Grüttner C., Teller J. New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications. J. Magn. Magn. Mater. 194:1999;8-15
52. Högemann D., Josephson L., Weissleder R., Basilion J.P. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug. Chem. 11:2000;941-946
53. Berry C.C., Wells S., Charles S., Curtis A.S.G. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials. 24:2003;4551-4557
54. Weissleder R., Bogdanov A., Neuwelt E.A., Papisov M. Long-circulating iron oxides for MR imaging. Adv. Drug Del. Rev. 16:1995;321-334
55. Jung C.W., Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging. 13:1995;661-674
56. Chouly C., Pouliquen D., Lucet I., Jeune J.J., Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 3:1996;245-255
57. Papisov M., Osada E., Okudzaki H., Ivabushi T. Polymer-inorganic composites produced by matrix condensation of titanium (IV) hydroxide in the presence of polyethylene glycol. Polym. Sci. 35:1993;105-108
58. Silveira A.M., Ponchel G., Puisieux F., Duchêne D. Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 15:1998;1051-1055
59. Boudad H., Legrand P., Lebas G., Cheron M., Duchêne D., Ponchel G. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int. J. Pharm. 218:2001;113-124
60. A. Monza da Silveira, G. Ponchel, P. Couvreur, F. Puisieux, Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins, WO Patent, 99/43359, 1999.
61. Duchêne D., Ponchel G., Wouessidjewe D. Cyclodextrins in targeting application to nanoparticles. Adv. Drug Del. Rev. 36:1999;29-40
62. Douglas S.J., Illum L., Davis S.S. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. J Colloid Interface Sci. 103:1985;154-163
63. Yang S.C., Ge H.X., Hu Y., Jiang X.Q., Yang C.Z. Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan. Colloid Polym. Sci. 278:2000;285-292
64. M. Aboubakar, A. Maksimenko, C. Chaumont, V. Polard, Système de vectorisation comprenant des nanoparticules de taille homogène d'au moins un polymère et d'au moins un polysaccharide chargé positivement et son procédé de préparation, PCT/FR 03/01909, 2003.
65. Richardson S., Kolbe H., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178:1999;231-243
66. Chern C.S., Lee C.K., Tsai Y.J. Dextran stabilized poly(methyl methacrylate) latex particles and their potential application for affinity purification of lectins. Colloid Polym. Sci. 275:1997;841-849
67. Passirani C., Ferrarini L., Barratt G., Devissaguet J.P., Labarre D. Preparation and characterization of nanoparticles bearing heparin or dextran covalently-linked to poly(methyl methacrylate). J. Biomater. Sci. Polym. Ed. 10:1999;47-62
68. Chauvierre C., Labarre D., Couvreur P., Vauthier C. Radical emulsion polymerization of alkylcyanoacrylates initiated by the redox system dextran-cerium (IV) under acidic aqueous conditions. Macromolecules. 36:2003;6018-6027
69. Chauvierre C., Labarre D., Couvreur P., Vauthier C. Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm. Res. 20:2003;1786-1793
70. Gref R., Rodrigues J., Couvreur P. Polysaccharides grafted with polyesters: novel amphiphilic copolymers for biomedical applications. Macromolecules. 35:2002;9861-9867
71. Lemarchand C., Couvreur P., Vauthier C., Costantini D., Gref R. Study of emulsion stabilization by graft copolymers using the optical analyser Turbiscan. Int. J. Pharm. 254:2003;77-82
72. Lemarchand C., Couvreur P., Besnard M., Costantini D., Gref R. Novel polyester-polysaccharide nanoparticles. Pharm. Res. 20:2003;1284-1292
73. Rodrigues J., Santo-Magalhaes N.S., Coehlo L.C.B.B., Couvreur P., Ponchel G., Gref R. Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. J. Control. Release. 92:2003;103-112
74. Olivier J.-C., Vauthier C., Taverna M., Puisieux F., Ferrier D., Couvreur P. Stability of orosumucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum. J. Control. Release. 40:1996;157-168
75. C. Lemarchand, R. Gref, S. Lesieur, H. Hommel, M. Besnard, D. Costantini, P. Couvreur, Novel dextran decorated polyester nanoparticles: demonstration of the core-shell structure, Submitted for publication.
76. Fournier C., Leonard M., Dellacherie E., Chikhi M., Hommel H., Legrand A.P. EPR spectroscopy analysis of hydrophobically modified dextran-coated polystyrene. J. Colloid Interface Sci. 198:1998;27-33
77. Chauvierre C., Vauthier C., Labarre D., Hommel H. Evaluation of the surface properties of dextran coated poly(isobutylcyanoacrylate) nanoparticles by spin-labelling coupled with electron resonance spectroscopy. Colloid Polym. Sci. 2004;. (in press)
78. Quellec P., Gref R., Perrin L., Dellacherie E., Sommer F., Verbavatz J.M., Alonso M.J. Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J. Biomed. Mater. Res. 42:1998;45-54
79. Passirani C., Barratt G., Devissaguet J.P., Labarre D. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci. 62:1998;775-785
80. Passirani C., Barratt G., Devissaguet J.P., Labarre D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methylmethacrylate). Pharm. Res. 15:1998;1046-1050
81. Jaulin N., Appel M., Passirani C., Barratt G., Labarre D. Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). J. Drug Target. 8:2000;165-172
82. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications - a review. J. Drug Target. 6:1998;167-174
83. Shen T., Weissleder R., Papisov M., Bogdanov A., Brady T. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29:1993;599-604
84. Weissleder R., Heautot J.F., Schafer B.K., Nossiff N., Papisov M.I., Bogdanov A., Brady T.J. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology. 191:1994;225-230
85. Moore A., Weissleder R., Bogdanov A. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J. Magn. Reson. Imaging. 7:1997;1140-1145
86. Zimmer C., Weissleder R., Kirtland P., Bogdanova A., Wright S.C., Enochs W.S. MR imaging of phagocytosis in experimental glioma. Radiology. 197:1995;533-538
87. Lind K., Kresse M., Debus N.P., Müller R.H. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J. Drug Target. 10:2002;221-230
88. Clément O., Guimaraes R., de Kerviler E., Frija G. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles. Invest. Radiol. 29:1994;S226-S228
89. Moore A., Marecos E., Bogdanov A., Weissleder R. Tumoral distribution of long circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 214:2000;568-574
90. Enochs W.S., Harsh G., Hochberg R., Weissleder R. Improved delineation of human brain tumors on MR images using long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging. 9:1999;228-232
91. Varallyay P., Nesbit G., Muldoon L.L., Nixon R.R., Delashaw J., Cohen J.I., Petrillo A., Rink D., Neuwelt E.A. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. Am. J. Neuroradiol. 23:2002;510-519
92. Weissleder R., Papisov M. Pharmaceutical iron oxides for MR imaging. Rev. Magn. Reson. Med. 4:1992;1-20
93. Runge V.M. Safety of approved MR contrast media for intravenous injection. J. Magn. Reson. Imaging. 12:2000;205-213
94. Jordan A., Scholz R., Wust P., Schirra H., Schiestel T., Schmidt H., Felix R. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effector intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 194:1999;185-196
95. Brusentsov N.A., Gogosov V.V., Brusentsova T.N., Sergeev A.V., Jurchenko N.Y., Kuznetsov A.A., Kuznetsov O.A., Shumakov L.I. Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma. J. Magn. Magn. Mater. 225:2001;113-117
96. Tokumitsu H., Hiratsuka J., Sakurai Y., Kobayashi T., Ichikawa H., Fukumori Y. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett. 150:2000;177-182
97. Zobel H.P., Kreuter J., Werner D., Noe C.R., Kumel G., Zimmer A. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:1997;483-493
98. Zimmer A. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods. 18:1999;286-295. see also page 322
99. Lallemand F., Felt-Baeyens O., Besseghir K., Behar-Cohen F., Gurny R. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur. J. Pharm. Sci. 56:2003;307-318
100. Calvo P., Alonso M.J., Vila Jato J.L., Robinson J.R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48:1996;1147-1152
101. Calvo P., Remunan-Lopez C., Vila Jato J.L., Alonso M.J. Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron emulsions. Colloid Polym. Sci. 275:1997;46-53
102. Calvo P., Thomas C., Alonso M.J., Vila-Jato J.L., Robinson J.R. Study of the mechanism of interaction of poly(epsilon-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. Int. J. Pharm. 103:1994;283-291
103. Calvo P., Vila-Jato J.L., Alonso M.J. Evalution of cationic polymer-coated nanocapsules as ocular drug delivery. Int. J. Pharm. 153:1997;41-50
104. De Campos A.M., Sanchez A., Gref R., Calvo P., Alonso M.J. The effect of a PEG versus chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur. J. Pharm. Sci. 20:2003;73-81
105. Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1994;1358-1361